Incidence and time trends of sarcoma (2000-2013): results from the French network of cancer registries (FRANCIM)

BMC Cancer
Brice AmadeoEmmanuel Desandes

Abstract

The exhaustive collection of new sarcoma cases and their second histologic review offer a unique opportunity to study their incidence and time trends in France according to the major subtypes. Data were collected from population-based cancer registries covering 22% of the French population. Crude and world age-standardized incidence rates (ASR) were estimated according to anatomic, histological and genetic groups, age and sex over the 2010-2013 period. Time trends in incidence were calculated by the annual percent change over the 2000-2013 period. During the most recent period (2010-2013), 3942 patients with sarcoma were included. The ASR of soft-tissue and bone sarcomas, and gastro-intestinal stromal tumors (GIST) were 2.1, 1.0 and 0.6, respectively. For the four most frequent histological subtypes (unclassified, leiomyosarcoma, GIST and liposarcoma), the ASR ranged from 0.4 to 0.7. ASRs were 1.9 for complex genomic and 1.3 for recurrent translocation sarcomas. The time-trend analysis showed a significant increase of sarcoma incidence rate between 2000 and 2005, which stabilized thereafter. Incidence rates increased for four histological subtypes (GIST, chondrosarcoma, myxofibrosarcoma, solitary fibrous tumors) and decreased f...Continue Reading

References

Dec 20, 2005·Histopathology·C R Antonescu
Oct 28, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C WibmerR Windhager
Jul 5, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kristin P AnfinsenTom Grotmol
Oct 6, 2012·Clinical Sarcoma Research·Zachary BurninghamJoshua D Schiffman
Oct 20, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C A StillerUNKNOWN RARECARE Working Group
Jun 20, 2013·Japanese Journal of Clinical Oncology·Etsuko NomuraHideaki Tsukuma
Nov 29, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S Mathoulin-PélissierA Italiano
Feb 27, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Tihomir DugandzijaMaja Ilic
Jun 10, 2015·Cancer Causes & Control : CCC·Patricia C ValeryFreddie Bray
Feb 13, 2016·The Lancet Oncology·Jean-Yves BlayIsabelle Ray-Coquard
Aug 23, 2017·PloS One·Kathryn E RoyseElizabeth Y Chiao
Sep 15, 2019·Cancer Epidemiology·Attila KollárUNKNOWN NICER Working Group

❮ Previous
Next ❯

Citations

Apr 23, 2020·Critical Reviews in Oncology/hematology·Nicolas PenelYves-Marie Robin
May 25, 2021·Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association·Hidetatsu OutaniSeiji Okada
Nov 13, 2021·Pediatric Blood & Cancer·Katrina M IngleySandra J Strauss

❮ Previous
Next ❯

Software Mentioned

RARECARE
Joinpoint Trend Analysis
Etiosarc

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.